Updated Review and Clinical Recommendations for the Diagnosis and Treatment of Patients with Retroperitoneal Sarcoma by the Spanish Sarcoma Research Group (GEIS).
Rosa Álvarez ÁlvarezAránzazu ManzanoCarolina Agra PujolVicente Artigas RaventósRaquel CorreaJosefina Cruz JuradoJuan Angel FernandezXavier Garcia Del MuroJose Antonio GonzalezNadia HindiPablo Lozano LomincharJavier Martínez TruferoRamiro J MéndezMercedes MuñozCristobal Muñoz CasaresFrancisco Orbis CastellanosRuth OrellanaMiguel Paniagua GonzálezAndres RedondoClaudia Valverde MoralesJosé Manuel AsencioPublished in: Cancers (2023)
Soft tissue sarcomas (STS) are an uncommon and biologically heterogeneous group of tumors arising from mesenchymal cells. The incidence is estimated at five cases per 100,000 people per year. Retroperitoneal sarcomas (RPS) account for 10-15% of all STS, and their management depends on their anatomical characteristics and histotype. Due to their very low incidence, it is recommended that RPS be treated in reference centers and evaluated by an experienced multidisciplinary team (MDT). In Spain, the Spanish Group for Research in Sarcomas (GEIS) brings together experts from various specialties to promote research on sarcomas and improve treatment results. This paper summarizes the GEIS recommendations for the diagnosis, treatment, and follow-up of patients with RPS.